Erectile dysfunction: Evaluation and pathophysiology

Tolulope Bakare; Ramy Abou Ghayda

doi:10.1016/B978-0-12-801238-3.64769-4

Erectile dysfunction: Evaluation and pathophysiology

Tolulope Bakare, Ramy Abou Ghayda

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Erectile dysfunction is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance and vaginal intercourse. The causes of erectile dysfunction can be grouped into two main categories: Psychogenic causes including psychological disorders, stress, performance anxiety, and organic caused including hormonal alteration, neurovascular, drug induced or anatomical abnormalities. Phosphodiesterase type V inhibitors (PDE5I) are FDA approved first line of treatment foe erectile dysfunction.

Original language	English (US)
Title of host publication	Encyclopedia of Reproduction
Publisher	Elsevier
Pages	184-186
Number of pages	3
ISBN (Electronic)	9780128151457
DOIs	https://doi.org/10.1016/B978-0-12-801238-3.64769-4
State	Published - Jan 1 2018
Externally published	Yes

Keywords

Cardiovascular diseases
Erectile dysfunction
Intracavernosal therapy
Intraurethral therapy
Organic etiologies
Penile anatomy
Penile prosthesis
Phosphodiesterase inhibitors
Physiology of erection
Psychogenic etiologies
Sexual performance
Vacuum devices
Vaginal intercourse

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/B978-0-12-801238-3.64769-4

Cite this

@inbook{ad08af6f035e409090bc1630bd5d2454,

title = "Erectile dysfunction: Evaluation and pathophysiology",

abstract = "Erectile dysfunction is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance and vaginal intercourse. The causes of erectile dysfunction can be grouped into two main categories: Psychogenic causes including psychological disorders, stress, performance anxiety, and organic caused including hormonal alteration, neurovascular, drug induced or anatomical abnormalities. Phosphodiesterase type V inhibitors (PDE5I) are FDA approved first line of treatment foe erectile dysfunction.",

keywords = "Cardiovascular diseases, Erectile dysfunction, Intracavernosal therapy, Intraurethral therapy, Organic etiologies, Penile anatomy, Penile prosthesis, Phosphodiesterase inhibitors, Physiology of erection, Psychogenic etiologies, Sexual performance, Vacuum devices, Vaginal intercourse",

author = "Tolulope Bakare and Ghayda, {Ramy Abou}",

year = "2018",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-801238-3.64769-4",

language = "English (US)",

pages = "184--186",

booktitle = "Encyclopedia of Reproduction",

publisher = "Elsevier",

}

TY - CHAP

T1 - Erectile dysfunction

T2 - Evaluation and pathophysiology

AU - Bakare, Tolulope

AU - Ghayda, Ramy Abou

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Erectile dysfunction is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance and vaginal intercourse. The causes of erectile dysfunction can be grouped into two main categories: Psychogenic causes including psychological disorders, stress, performance anxiety, and organic caused including hormonal alteration, neurovascular, drug induced or anatomical abnormalities. Phosphodiesterase type V inhibitors (PDE5I) are FDA approved first line of treatment foe erectile dysfunction.

AB - Erectile dysfunction is defined as the inability to achieve or maintain an erection sufficient for satisfactory sexual performance and vaginal intercourse. The causes of erectile dysfunction can be grouped into two main categories: Psychogenic causes including psychological disorders, stress, performance anxiety, and organic caused including hormonal alteration, neurovascular, drug induced or anatomical abnormalities. Phosphodiesterase type V inhibitors (PDE5I) are FDA approved first line of treatment foe erectile dysfunction.

KW - Cardiovascular diseases

KW - Erectile dysfunction

KW - Intracavernosal therapy

KW - Intraurethral therapy

KW - Organic etiologies

KW - Penile anatomy

KW - Penile prosthesis

KW - Phosphodiesterase inhibitors

KW - Physiology of erection

KW - Psychogenic etiologies

KW - Sexual performance

KW - Vacuum devices

KW - Vaginal intercourse

UR - http://www.scopus.com/inward/record.url?scp=85079263018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079263018&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-801238-3.64769-4

DO - 10.1016/B978-0-12-801238-3.64769-4

M3 - Chapter

AN - SCOPUS:85079263018

SP - 184

EP - 186

BT - Encyclopedia of Reproduction

PB - Elsevier

ER -

Erectile dysfunction: Evaluation and pathophysiology

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this